Jun. 24 at 7:43 PM
$COSM 3:42 PM EDT, June 24, 2026 (Benzinga Newswire)
Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today provided an update on the growing momentum of C-Sept™ PRO, a proprietary antiseptic solution from its high-margin infection-control portfolio, across leading public and private hospital groups in Greece.
C-Sept PRO has generated average monthly sales exceeding
$93,000 over the past six months, accelerating to more than
$108,000 per month over the past three months. This momentum places the product on track for annualized sales of over
$1.3 million, generating approximately
$0.9 million in annualized gross profit at a gross margin of approximately 72%. Demand has been driven by adoption across major public and private Greek hospital groups and a consistent pattern of repeat ordering, with growing momentum further supported by the Company’s participation in public hospital tenders.
